PDCD1 and neoplasm: Tumor mutational burden (TMB), strongly associated with the response to PD-1/PD-L1 inhibitors, and microsatellite instability (MSI), resulting from DNA mismatch repair defects in tumor tissues, are characterized by the presence of a new microsatellite allele at a tumor locus due to repetitive unit insertions or deletions.